Michelle A Rudek (Michael A Carducci)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 28

Top Topics

Ankylosing Spondylitis

Positive Breast Cancer

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Veronica Rendo, Eudocia Quant Lee, Connor Bossi, Nicholas Khuu, Michelle A Rudek, Sangita Pal, Abigail R N Reynolds, Auriole C R Fassinou, Georges Ayoub, Emily Lapinskas, William Pisano, John Jeang, Sylwia A Stopka, Michael S Regan, Johan Spetz, Arati Desai, Frank Lieberman, Joy D Fisher, Kristine Pelton, Raymond Y Huang, Louis B Nabors, Matthias Holdhoff, Neeraja Danda, Roy Strowd, Serena Desideri, Tobias Walbert, Xiaobu Ye, Nathalie Y R Agar, Stuart A Grossman, Brian M Alexander, Patrick Y Wen, Keith L Ligon, Rameen Beroukhim
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma. medRxiv : the preprint server for health sciences (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, Vikrant Palande, Michelle A Rudek, Richard B S Roden
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer. PloS one 19 (7) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, Vikrant Palande, Michelle A Rudek, Richard B S Roden
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer. PloS one 19 (7) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Ravi K Anchoori, Ssu-Hsueh Tseng, Hua-Ling Tsai, Vikrant Palande, Michelle A Rudek, Richard B S Roden
Preclinical studies of RA475, a guanidine-substituted spirocyclic candidate RPN13/ADRM1 inhibitor for treatment of ovarian cancer. PloS one 19 (7) (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer 5 (6) (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response rate and molecular correlates to encorafenib and binimetinib in BRAF-V600E mutant high-grade glioma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Evanthia T Roussos Torres, Won Jin Ho, Ludmila Danilova, Joseph A Tandurella, James Leatherman, Christine Rafie, Chenguang Wang, Adam M Brufsky, Patricia M LoRusso, Vincent Chung, Yuan Yuan, Melinda Downs, Ashley O'Connor, Sarah M Shin, Alexei Hernandez, Elizabeth L Engle, Richard Piekarz, Howard Streicher, Zahra Talebi, Michelle A Rudek, Qingfeng Zhu, Robert A Anders, Ashley Cimino-Mathews, Elana J Fertig, Elizabeth D Thompson, Vered Stearns, Caitriona Cahir
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer (2024)
Karisa C Schreck, Strowd Re, Louis Burt Nabors, Benjamin M Ellingson, Michael Chang, Sze Kiat Tan, Zied Abdullaev, Rust Turakulov, Kenneth D Aldape, Neeraja Danda, Serena Desideri, Joy Fisher, Michaella Iacoboni, Trisha Surakus, Michelle A Rudek, Chetan Bettegowda, Stuart A Grossman, Xiaobu Ye
Response Rate and Molecular Correlates to Encorafenib and Binimetinib in BRAF-V600E Mutant High-Grade Glioma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Missak Haigentz, Jeannette Y Lee, Elizabeth Yu Chiao, David M Aboulafia, Lee Ratner, Richard F Ambinder, Robert A Baiocchi, Ronald T Mitsuyasu, William Wachsman, Joseph A Sparano, Michelle A Rudek
Phase I trial of the multi-kinase inhibitor cabozantinib, a CYP3A4 substrate, plus CYP3A4 interacting antiretroviral therapy in people living HIV and cancer (AMC087). Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Ryan D Gentzler, Liza C Villaruz, John C Rhee, Bethany Jablonski Horton, Joseph Mock, Michael Hanley, Kyeongmin Kim, Michelle A Rudek, Mitch A Phelps, Michael A Carducci, Richard L Piekarz, Kwon-Sik Park, Timothy N J Bullock, Charles M Rudin
Phase I Study of Entinostat, Atezolizumab, Carboplatin, and Etoposide in Previously Untreated Extensive-Stage Small Cell Lung Cancer, ETCTN 10399. The oncologist (2023)
Amanda B Kagan, Dominique A Garrison, Nicole M Anders, Jonathan A Webster, Sharyn D Baker, Srinivasan Yegnasubramanian, Michelle A Rudek
DNA methyltransferase inhibitor exposure-response: Challenges and opportunities. Clinical and translational science (2023)
Tuo Meng, Jinhua Zheng, Min Chen, Yang Zhao, Hadi Sudarjat, Aji Alex M R, Vineet Kulkarni, Yumin Oh, Shiyu Xia, Zheng Ding, Hyounkoo Han, Nicole Anders, Michelle A Rudek, Woon Nam Chow, Walter Stark, Laura M Ensign, Justin Hanes, Qingguo Xu
Six-month effective treatment of corneal graft rejection. Science advances 9 (12) (2023)
Amanda B Kagan, Blake S Moses, Rena Lapidus, Bryan T Mott, Ganesha Rai, Nicole M Anders, Stephen W Hoag, Michelle A Rudek, Curt I Civin
ART714 is a best-in-class antileukemic 2-carbon-linked dimeric artemisinin derivative. Cancer chemotherapy and pharmacology (2023)
Michael T Davis, Nicole M Anders, A Dimitrios Colevas, Troy E Messick, Michelle A Rudek
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of VK-2019, a selective EBNA1 inhibitor. Biomedical chromatography : BMC (2023)
Amanda B Kagan, Nicole M Anders, Avelina Hemingway, Eudocia Q Lee, Kevin R Kelly, Hans C Lee, Meng Xu-Welliver, Richard L Piekarz, Michelle A Rudek
Quantitation of navtemadlin in human plasma and brain tissue by liquid chromatography-tandem mass spectrometry. Biomedical chromatography : BMC 36 (11) (2022)
Susan C Scott, Nicole M Anders, Ping He, Avelina Hemingway, Steven D Gore, Christine L Hann, Michelle A Rudek
Validation of a robust and rapid liquid chromatography tandem mass spectrometric method for the quantitative analysis of navitoclax. Biomedical chromatography : BMC (2021)
Evanthia T Roussos Torres, Christine I Rafie, Chenguang Wang, David Lim, Adam Brufsky, Patricia LoRusso, Joseph Paul Eder, Vincent Chung, Melinda Downs, Molly Geare, Richard L Piekarz, Howard Streicher, Leslie Anforth, Michelle A Rudek, Qingfeng Zhu, Sepideh Besharati, Ashley Cimino-Mathews, Robert A Anders, Vered Stearns, Elizabeth D Thompson, Roisin M Connolly
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844). Clinical cancer research : an official journal of the American Association for Cancer Research 27 (21) (2021)
Roisin M Connolly, Eric Laille, Ulka Vaishampayan, Vincent Chung, Karen Kelly, Afshin Dowlati, Olatunji B Alese, Robert Donald Harvey, Paul Haluska, Lillian L Siu, Shivaani Kummar, Richard Piekarz, S Percy Ivy, Nicole M Anders, Melinda Downs, Ashley O'Connor, Angela Scardina, Jacqueline Saunders, Gary L Rosner, Michelle A Rudek, null null
Phase I and Pharmacokinetic Study of Romidepsin in Patients with Cancer and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (20) (2020)
Razelle Kurzrock, Douglas W Ball, Marianna L Zahurak, Barry D Nelkin, Vivek Subbiah, Shabina Ahmed, Ashley O'Connor, Enusha Karunsena, Rose M Parkinson, Justin A Bishop, Yoonji Ha, Rajni Sharma, Christopher D Gocke, Ralph Zinner, Michelle A Rudek, Steven I Sherman, Nilofer S Azad
A Phase I Trial of the VEGF Receptor Tyrosine Kinase Inhibitor Pazopanib in Combination with the MEK Inhibitor Trametinib in Advanced Solid Tumors and Differentiated Thyroid Cancers. Clinical cancer research : an official journal of the American Association for Cancer Research 25 (18) (2019)